http://www.aktiencheck.de aktiencheck.de aktiencheck.de Mon, 27 Apr 2026 10:35:59 +0200 2 http://www.aktiencheck.de/forum/Avita_Medical_Nachfolgethread_AvitaTherapeutics-A2P733-t570451 http://www.aktiencheck.de/forum/Avita_Medical_Nachfolgethread_AvitaTherapeutics-A2P733-t570451 1.Q 2022 Highlights - no debt ! $60.4M ca$h, Zitat:" financial results for its first fiscal quarter ended September 30, 2021. First Quarter Fiscal Year 2022 Highlights..... Total revenue increased 39% to $7.0 million compared to $5.1 million in the first fiscal quarter of 2021.... Gross profit margin improved 3% to 85% compared to the first fiscal quarter of 2021.... Total operating expenses decreased 18% to $12.3 million compared to $14.9 million in the first fiscal quarter of 2021.... Net loss of $5.9 million, or $0.24 per share compared to a net loss of $10.2 million, or $0.48 per share in the first fiscal quarter of 2021.... As of September 30, 2021, the Company had $60.4 million in cash and cash equivalents and $49.5 million in short-term and long-term marketable securities, and no debt....."Ende Zitat Source:https://www.stockwatch.com/News/Item/U-z8388525-U!RCEL-20211108/U/RCEL Links: https://ir.avitamedical.com/ https://www.barchart.com/stocks/quotes/RCEL/interac [<a href="http://www.aktiencheck.de/forum/Avita_Medical_Nachfolgethread_AvitaTherapeutics-A2P733-t570451">mehr</a>]